Clik here to view.
Versiante renews research deal with BC Cancer Agency
Verisante Technology (TSX-V:VRS) has renewed its collaborative research agreement with the BC Cancer Agency for another 13 months and will contribute about $250,000 over the course of the agreement to...
View ArticleClik here to view.
Verisante readies Aura launch for skin cancer
Verisante Technology (TSX-V:VRS; OTCQX: VRSEF) is hoping to begin sales in the fall of a breakthrough skin cancer detection device, Verisante Aura, which has been approved in Canada, Europe and...
View ArticleClik here to view.
Verisante in distributor pact with BO-Pharma
Verisante Technology (TSX-V:VRS; OTCQX: VRSEF) has entered into an exclusive agreement with BO-Pharma BV to distribute Verisante Aura in Belgium, the Netherlands and Luxemburg. “BO-Pharma is the...
View ArticleClik here to view.
Verisante lung cancer detection technology effective
Verisante Technology (TSX-V:VRS; OTCQX: VRSEF) has learned that a research team at the B.C. Cancer Agency is presenting a poster on new study results for lung cancer at the agency’s annual cancer...
View ArticleClik here to view.
Laserwelt to distribute Verisante Aura in Germany
Verisante Technology (TSX-V:VRS; OTCQX:VRSEF) has entered into an exclusive agreement with Laserwelt to distribute the Verisante Aura skin cancer detection device in Germany, Austria and Liechtenstein....
View ArticleClik here to view.
Verisante receives purchase orders for Aura
Verisante Technology (TSX-V:VRS) has received purchase orders for Verisante Aura from the company’s exclusive distributors in Canada and Europe, and expects shipments to begin in February. “This is a...
View ArticleClik here to view.
Verisante signs Swiss distribution deal for Aura
Verisante Technology (TSX-V:VRS) has entered into an exclusive agreement with Pacifica Handels AG to distribute Verisante Aura in Switzerland and also support technical training and servicing....
View ArticleClik here to view.
Verisante receives F&S technology innovation award
Verisante Technology (OTCQX:VRSEF; TSX-V:VRS) has received the Frost & Sullivan 2014 North American Technology Innovation Leadership of the Year Award for In Vivo Cancer Detection for its skin...
View ArticleClik here to view.
Verisante displays Aura at BC Cancer Foundation
Verisante Technology (OTCQX:VRSEF; TSX-V:VRS) is partnering with the BC Cancer Foundation to showcase Verisante Aura, a device for the rapid detection of skin cancer. Aura “We are very appreciative of...
View Article
